share_log

Maxim Group Maintains Buy on Quoin Pharmaceuticals, Lowers Price Target to $4

Moomoo 24/7 ·  Mar 15 11:15

Maxim Group analyst Naz Rahman maintains Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy and lowers the price target from $15 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment